血小板-中性粒细胞凝集介导的线粒体NETosis在SFTSV重症/危重症感染中的作用机制研究
批准号:
82072295
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
陈志海
依托单位:
学科分类:
人乳头瘤病毒、狂犬病毒、细小病毒、朊病毒及其他病毒与感染
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
陈志海
中文摘要
发热伴血小板减少综合征病毒(SFTSV)感染可引起致死性出血热。血小板减少是SFTS多器官衰竭的始动因素,但机制不明。近年发现血小板-中性粒细胞凝集既能造成血小板减少,又能触发中性粒细胞胞外诱捕网(NETs)释放。NETs是造成组织损伤的细胞外DNA-蛋白质复合物。我们前期发现NETs升高与血小板减少有关,且是SFTS患者预后不良的新标志;但非经典的染色质NETs,而是线粒体NETs。据此提出:血小板-中性粒细胞凝集破坏Ca2+稳态,触发线粒体NETs释放,从而造成SFTS多器官衰竭。本项目拟通过临床队列和小鼠模型明确线粒体NETs在SFTS重症化过程中的作用,阐明凝集的分子途径以及进而引起Ca2+内流、线粒体NETs释放(即NETosis)的机制。采用抗凝剂、NETs抑制剂反向验证,探讨干预线粒体NETosis的分子靶点,阐明SFTS重症化机制,为降低病死率提供新的免疫治疗策略。
英文摘要
Severe fever with thrombocytopenia syndrome virus (SFTSV) infection can cause hemorrhagic fever, with a serious condition and a high mortality rate. Thrombocytopenia is the initiating factor for multiple organ failure in SFTS, but the mechanism is still unknown. In recent years, it has been discovered that "platelet-neutrophil aggregation" is both an immunological cause of thrombocytopenia and a fuse triggering the release of neutrophil extracellular traps (NETs). NETs are extracellular DNA-protein complexes that cause inflammatory damage of tissues. We preliminary found that the levels of NETs were negatively correlated with the numbers of platelets, and are also a novel biomarker of poor prognosis in SFTS. However, SFTS patients were dominated by mitochondrial NETs rather than classic chromatin NETs. Accordingly, it is proposed that the platelet-neutrophil aggregation disrupts the calcium homeostasis and subsequently triggers the release of mitochondrial NETs, results in multiple organ failure in SFTS. We intend to clarify the pathological role of mitochondrial NETs in severe SFTSV infection through clinical cohort and mouse models; to investigate the molecular pathway of platelet-neutrophil aggregation and the mechanism that causes calcium influx and mitochondrial NETs release (NETosis); finally, to perform the verification assays by using anticoagulants and NETs inhibitors in vivo and in vitro. The aim of this project is to explore the molecular targets of mitochondrial NETosis to clarify the mechanism of SFTS severe / critical infection and to provide a new immunotherapy strategy to reduce the mortality.
发热伴血小板减少综合征(severe fever with thrombocytopenia syndrome, SFTS)是2009年在我国首次发现的一种病毒性出血热,病死率高达30%。血小板减少是SFTS多器官衰竭的重要始动因素,但具体机制尚不明确。研究表明,血小板-中性粒细胞凝集既能导致血小板减少,又可触发中性粒细胞胞外诱捕网(neutrophil extracellular traps, NETs)释放,而NETs会加重组织损伤。前期发现,SFTS患者中NETs升高与血小板减少和预后不良密切相关,以线粒体NETs为主。因此本研究旨在阐明线粒体NETosis的作用机制,为降低病死率提供新的免疫治疗思路。我们利用流式细胞术筛选与疾病结局和进展相关的中性粒细胞表面标志物,结合体外实验验证线粒体NETs的病理损伤作用、细胞感染模型探究血小板-中性粒细胞凝集的形成机制及其诱导线粒体NETs释放的分子机制,确了线粒体NETs在SFTS重症化中的致病作用,同时构建了SFTSV小鼠模型,分析线粒体NETs与心、肝、肾、肺等器官损伤的关系,并验证NETs抑制剂的治疗效果。还结合了队列研究,筛选与SFTS多器官损伤及不良预后相关的血浆蛋白标志物,鉴定出CCL20为预测SFTS预后的一种高特异性新型蛋白标志物。完善了重症和死亡预警体系,发现了一系列新的临床和实验室预测指标,如高C反应蛋白与白蛋白比值(CAR),嗜酸性粒细胞百分比(EOS%)和嗜碱性粒细胞百分比(BAS%),甘油三酯-葡萄糖指数(TyG)等,这些成果为SFTS的诊断、预警和治疗提供了重要科学依据,为降低病死率开辟了新的思路。
血小板-中性粒细胞凝集介导的线粒体NETosis在SFTSV重症/危重症感染中的作用机制研究
-
批准号:--
-
项目类别:--
-
资助金额:55万元
-
批准年份:2020
-
负责人:陈志海
-
依托单位:
国内基金
海外基金